BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31989570)

  • 1. Detection and Characterization of Oncogene Mutations in Preneoplastic and Early Neoplastic Lesions.
    Minamoto T
    Methods Mol Biol; 2020; 2102():419-437. PubMed ID: 31989570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions.
    Minamoto T
    Methods Mol Biol; 2005; 291():263-78. PubMed ID: 15502229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions.
    Minamoto T
    Methods Mol Biol; 2014; 1105():381-98. PubMed ID: 24623243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sampling method as a key factor in identifying K-ras oncogene mutations in preneoplastic colorectal lesions.
    Ronai Z; Minamoto T; Butler R; Tobi M; Luo FQ; Zang E; Esumi H; Sugimura T
    Cancer Detect Prev; 1995; 19(6):512-7. PubMed ID: 8925520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras mutations in putative preneoplastic lesions in human colon.
    Pretlow TP; Brasitus TA; Fulton NC; Cheyer C; Kaplan EL
    J Natl Cancer Inst; 1993 Dec; 85(24):2004-7. PubMed ID: 8246286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras and p53 mutations in human colorectal aberrant crypt foci.
    Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
    J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer.
    Lev Z; Kislitsin D; Rennert G; Lerner A
    J Cell Biochem Suppl; 2000; 34():35-9. PubMed ID: 10762013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
    Hu Y; Le Leu RK; Young GP
    Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.
    Thebo JS; Senagore AJ; Krygier S; Luchtefeld MA
    Am Surg; 2001 Aug; 67(8):802-5. PubMed ID: 11510588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
    Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
    Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.
    Nishikawa T; Maemura K; Hirata I; Matsuse R; Morikawa H; Toshina K; Murano M; Hashimoto K; Nakagawa Y; Saitoh O; Uchida K; Katsu K
    Clin Chim Acta; 2002 Apr; 318(1-2):107-12. PubMed ID: 11880119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces.
    Ratto C; Flamini G; Sofo L; Nucera P; Ippoliti M; Curigliano G; Ferretti G; Sgambato A; Merico M; Doglietto GB; Cittadini A; Crucitti F
    Dis Colon Rectum; 1996 Nov; 39(11):1238-44. PubMed ID: 8918432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
    Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
    Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.
    Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
    Gastroenterology; 1995 Feb; 108(2):434-40. PubMed ID: 7835585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues.
    Monstein HJ; Fransén K; Dimberg J; Söderkvist P
    Eur J Clin Invest; 2004 Feb; 34(2):100-6. PubMed ID: 14764072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples.
    Ward R; Hawkins N; O'Grady R; Sheehan C; O'Connor T; Impey H; Roberts N; Fuery C; Todd A
    Am J Pathol; 1998 Aug; 153(2):373-9. PubMed ID: 9708798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa.
    Jacoby RF; Llor X; Teng BB; Davidson NO; Brasitus TA
    J Clin Invest; 1991 Feb; 87(2):624-30. PubMed ID: 1991846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.